SpringWorks Therapeutics | 4:持股变动声明-董事 MACKAY MARTIN
SpringWorks Therapeutics | 3:首次持股声明-董事 MACKAY MARTIN
SpringWorks Therapeutics | 4:持股变动声明-高管 Cassidy James
SpringWorks Therapeutics | 4:持股变动声明-高管 Edris Badreddin
SpringWorks Therapeutics | 4:持股变动声明-董事 Hambleton Julie
SpringWorks Therapeutics | 4:持股变动声明-高管 Islam Saqib
SpringWorks Therapeutics | 4:持股变动声明-董事 Hambleton Julie
SpringWorks Therapeutics | 4:持股变动声明-董事 Fuhrman Alan
SpringWorks Therapeutics | 4:持股变动声明-董事 LYNCH DANIEL
SpringWorks Therapeutics | 4:持股变动声明-董事 Lewis-Hall Freda C
SpringWorks Therapeutics | 4:持股变动声明-董事 ALBAN CARLOS
SpringWorks Therapeutics | 4:持股变动声明-高管 Ashar Bhavesh
SpringWorks Therapeutics | 4:持股变动声明-高管 Pichl Daniel
SpringWorks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%)等
SpringWorks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(5.53%),Deep Track Biotechnology Master Fund, Ltd.(5.53%)等
SpringWorks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(8.38%)
SpringWorks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(15.000%),Abigail P. Johnson(15.000%)
SpringWorks Therapeutics | 4:持股变动声明-高管 Ashar Bhavesh
SpringWorks Therapeutics | 4:持股变动声明-高管 Pichl Daniel
SpringWorks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(7.5%)
暂无数据